4/2003 rev 2 i.4.13 – slide 1 of 46 session i.4.13 part i review of fundamentals module 4sources...

46
4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4 Sources of Radiation Session 13 Neutron Production IAEA Post Graduate Educational Course Radiation Protection and Safety of Radiation Sources

Upload: irene-mcdowell

Post on 12-Jan-2016

217 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 1 of 46

Session I.4.13

Part I Review of Fundamentals

Module 4 Sources of Radiation

Session 13 Neutron Production

IAEA Post Graduate Educational CourseRadiation Protection and Safety of Radiation Sources

Page 2: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 2 of 46

Overview

In this Session we will discuss how neutrons are produced and

We will also discuss how neutrons are used for medical neutron therapy

Page 3: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 3 of 46

Neutron Production

Neutrons carry no electrical charge and are thus "neutral"

Page 4: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 4 of 46

Fission

Page 5: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 5 of 46

3He and Neutron Production from Fusion

Page 6: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 6 of 46

Nuclear ReactionsFusion

Page 7: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 7 of 46

Deuterium-TritiumNeutron Generator

Page 8: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 8 of 46

Neutron Production by Spallation

Page 9: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 9 of 46

ISIS NeutronProduction Assembly

Page 10: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 10 of 46

Continuous SpallationNeutron Source

Page 11: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 11 of 46

US SpallationNeutron Source (SNS)

Page 12: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 12 of 46

Neutron Production

(p,n) reactions

(d,n) reactions

(α,n) reactions

Page 13: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 13 of 46

Nuclear ReactionsCharged Particle Bombardment

p + 68Zn 67Ga + 2n

α + 16O 18F + p + n

Page 14: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 14 of 46

Neutron Productionby Various Reactions

Page 15: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 15 of 46

Neutron Production (cont)

Page 16: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 16 of 46

Neutron therapy is a highly effective form of radiation therapy

Long-term experience with treating cancer has shown that certain tumor types are very difficult to kill using conventional radiation therapy

These types are classified as being "radioresistant"

Neutron therapy specializes in treating inoperable, radioresistant tumors occurring anywhere in the body

What is Neutron Therapy?

Page 17: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 17 of 46

Conventional radiation therapy includes photon (X-ray) and electron radiation, which is available at many clinics and hospitals

These beams are produced by electron accelerators or from radioactive sources such as cobalt

Particle therapy includes protons and neutrons, which are generated using proton accelerators

The basic effect of ionizing radiation is to destroy the ability of cells to divide and grow by damaging their DNA strands

What is Neutron Therapy?

Page 18: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 18 of 46

For photon, electron and proton radiation the damage is done primarily by activated radicals produced from atomic interactions

These types of radiation are called low linear-energy-transfer (low LET) radiation

With neutron radiation the damage is done primarily by nuclear interactions

Neutrons are high linear-energy-transfer (high LET) radiation

What is Neutron Therapy?

Page 19: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 19 of 46

If a tumor cell is damaged by low LET radiation it has a good chance to repair itself and continue to grow

With high LET radiation such as neutron radiation, the chance that a damaged tumor cell will repair itself is very small.

Because the biological effectiveness of neutrons is so high, the required tumor dose is about one-third the dose required with photons, electrons or protons

A full course of neutron therapy is delivered in only 10 to 12 treatments, compared to 30 - 40 treatments needed for low LET radiation

What is Neutron Therapy?

Page 20: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 20 of 46

The side effects of fast neutron therapy are similar to those of low LET therapy

Their severity depends on the total dose delivered and the general health of the patient

Effects on normal tissues are minimized by careful computerized treatment planning

What is Neutron Therapy?

Page 21: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 21 of 46

Neutrons were discovered by Sir James Chadwick in 1932

Just six years later, Dr. Robert Stone began clinical trials treating cancer with neutrons produced by E.O. Lawrence's cyclotron in Berkeley, California

These trials were terminated because the cyclotron was needed for the war effort during World War II

Clinical research began again in 1965 when Hammersmith Hospital in London began irradiating patients with neutron beams

History of Neutron Therapy

Page 22: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 22 of 46

By 1969, it was clear that for certain tumors, local control could be achieved using neutron irradiation

Encouraged by these results, the M.D. Anderson Hospital and Tumor Institute in Houston, the Naval Research Laboratory in Washington, D.C., and the University of Washington in Seattle began neutron therapy research

They started treating patients in the early 1970s.

History of Neutron Therapy

Page 23: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 23 of 46

Boron Neutron Capture Therapy (BNCT) is a radiotherapy modality for treating cancerous tumours (e.g. glioma – a cancer of the brain)

It utilizes the reaction between the 10B nucleus and slow (thermal) neutrons:

10B + n 7Li(0.84 MeV) + 4He(1.47 MeV) + γ(0.48 MeV)

The released 7Li atom and alpha-particle (4He) have a total energy of 2.31 MeV which is deposited within the range of approximately 5-9 mm (i.e. at a distance corresponding to about one cell diameter)

Boron Neutron Capture Therapy(BNCT)

Page 24: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 24 of 46

In principle, one boron-neutron interaction liberates enough energy to kill the cell in which the inter-action takes place

The short distance deposition of the released energy spares the surrounding boron-free tissue of the radiation damage

The effect of BNCT is dependent on two preconditions:

the selective accumulation of boron atoms in the target (tumour) rather than in the healthy cells

the tumour site is reached by a sufficient number of neutrons

Boron Neutron Capture Therapy(BNCT)

Page 25: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 25 of 46

Medical Neutron Therapy

Page 26: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 26 of 46

Medical Neutron Therapy

Page 27: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 27 of 46

Medical Neutron Therapy

Page 28: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 28 of 46

Medical Neutron Therapy

Page 29: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 29 of 46

Medical Neutron Therapy

Page 30: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 30 of 46

HEAD AND NECK - Salivary glands, tongue, pharynx, oral cavity, nasopharynx, brain tumorsCHEST - Localized tumors of lung, mediastinum, pleura, pericardium

ABDOMEN - Pancreas, colon, bile duct, gallbladder, ampula of vater, peritoneum

PELVIS - Prostate, bladder, uterus, rectosigmoid

EXTREMITIES AND TRUNK - Soft tissue, bone, cartilage

PALLIATIVE - Large tumors and metastasis from neutron-sensitive tumors

Medical Neutron Therapy

Page 31: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 31 of 46

Medical Neutron Therapy

Page 32: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 32 of 46

Medical Neutron Therapy

Page 33: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 33 of 46

Medical Neutron Therapy

Page 34: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 34 of 46

Medical Neutron Therapy

Page 35: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 35 of 46

Medical Neutron Therapy

Page 36: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 36 of 46

Place Country Source Mean Energy (MeV)

Obninsk Russia ReactorGarching Germany Reactor 1.8Chelyabinsk Russia d(0.5) + T 14.3Tomsk* Russia d(14) + Be 5.9Minsk* Belarus d(14) + Be 5.9Essen* Germany d(14.3) + Be 6.0

*Cyclotron

Fast Neutron Therapy Facilities(E < 30 MeV)

Page 37: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 37 of 46

Place Country Source

Orleans France p(34) + BeBeijingº China p(35) + BeDetroit, MI USA d(50) + BeSeattle, WA USA p(50) + BeSeoul+ South Korea p(50) + BeNice+ France p(60) + BeLouvain‑la‑Neuve+ Belgium p(65) + BeBatavia, IL USA p(66) + BeFaure South Africa p(66) + Be

+Not operational at presentºLinac (all other accelerators are cyclotrons)

Fast Neutron Therapy Facilities(E > 30 MeV)

Page 38: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 38 of 46

Neutrons

Although the previous slides have indicated the usefulness of neutron beams for medical therapy, neutrons can also be a nuisance byproduct of medical therapy such as in high energy Linear Accelerator facilities treating patients with high energy photons.

The remaining slides summarize this issue.

Page 39: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 39 of 46

Neutrons

Neutrons are produced by (gamma,n) reactions in high energy linear accelerators (E > 10MV)

Issues are neutron shielding and activation of items in the beam

Page 40: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 40 of 46

Neutron Shielding

Different concept from X-ray shielding

Neutrons scatter more

Attenuation (and scatter) depend VERY strongly on the neutron energy

Best shielding materials contain hydrogen or boron (with high cross sections for thermal neutrons)

Page 41: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 41 of 46

Features of Neutron Shielding

Long maze - many ‘bounces’

Neutron door - typically filled with borated paraffin wax

Care is required as neutrons generate gammas which may require other materials for shielding

Page 42: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 42 of 46

Activation

Neutrons can activate materials High energy linacs are designed around

materials with low activation cross section After high energy photon irradiation, beam

modifiers such as wedges or compensators may become activated

After prolonged use of high energy photons (e.g. for commissioning) it is advisable to let activation products decay prior to entering the room (>10min)

Page 43: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 43 of 46

More Information on Neutrons

Page 44: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 44 of 46

Neutron Evaluation

if the facility has an accelerator with an energy >15 MeV, then radiation scans should include a neutron survey, especially near the entrance to the maze

the survey instrument used for neutrons should be of a suitable type (see, for example, AAPM report 19)

Page 45: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 45 of 46

Where to Get More Information

Cember, H., Johnson, T. E., Introduction to Health Physics, 4th Edition, McGraw-Hill, New York (2008)

Martin, A., Harbison, S. A., Beach, K., Cole, P., An Introduction to Radiation Protection, 6th Edition, Hodder Arnold, London (2012)

Firestone, R.B., Baglin, C.M., Frank-Chu, S.Y., Eds., Table of Isotopes (8th Edition, 1999 update), Wiley, New York (1999)

Page 46: 4/2003 Rev 2 I.4.13 – slide 1 of 46 Session I.4.13 Part I Review of Fundamentals Module 4Sources of Radiation Session 13Neutron Production IAEA Post Graduate

4/2003 Rev 2 I.4.13 – slide 46 of 46

Where to Get More Information

Dendy, P. P., Heaton, B., et al, Physics for Diagnostic Radiology, CRC Press, London (2011)

International Commission on Radiological Protection, Publication 105, Radiation Protection in Medicine, Ann ICRP 37 (6) (2008)